2015-2019 France Cancer Diagnostics Industry: Market Segmentation Analysis - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals, Commercial Labs

August 2015 | 585 pages | ID: 24F1194635BEN
Venture Planning Group

Abstracts

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,350. The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

2015-2019 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs is VPGMarketResearch's new study of the major business opportunities emerging in the French cancer diagnostics market during the nextfive years. The report examines trends in the French market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the French cancer diagnostics market is promising to be an exciting, dynamic and rapidly expand ing field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

French Market Overview

• Five-year test volume and sales projections.
• Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.
• Estimated universe of laboratories performing cancer diagnostic testing.
• Cancer statistics, etiology and recent developments in France.

Business Opportunities and Strategic Recommendations

• Specific new product development opportunities with potentially significant market appeal during the next five years.
• Design criteria for new products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

• Oncogenes
• Biochemical Markers
• Growth Factors
• Colony Stimulating Factors
• Hormones
• Immunohistochemical Stains
• Lymphokines

Supplier Shares, Sales and Volume Forecasts

• Sales and market shares of major cancer diagnostic product suppliers by individual test.
• Five-year test volume and sales forecasts for major tumor markers by market segment, including:
• Hospitals
• Commercial/Private Laboratories

Instrumentation Review

• Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

• Assessment of latest technologies and their potential applications for cancer diagnostic testing.
• Review of competing/complementing technologies.
• Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

Strategic assessments ofmajor suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

The companies analyzed in the report include:

• Abbott
• AdnaGen
• Agilent Technologies
• Applied Gene Technologies
• Arca Biopharma
• Beckman Coulter/Danaher
• Becton Dickinson
• Biomedical Diagnostics
• bioMerieux
• Bio-Rad
• CellSearch
• Cepheid
• Correlogic Systems/Vermillion
• Decode Genetics
• Diadexus
• Diagnocure
• DiaSorin
• Eiken Chemical
• Elitech Group
• Epigenomics
• Enterix
• Enzo Biochem
• Exact Sciences
• Fujirebio
• Guided Therapeutics
• Hologic/Gen-Probe
• Kreatech/Leica
• Kyowa Medex
• Mackay Life Sciences
• Myriad Genetics
• OncoLab
• Ortho-Clinical Diagnostics
• Panacea Pharmaceuticals
• Polartechnics
• Polymedco
• PreMD
• Qiagen
• Quest Diagnostics
• Radient Pharmaceuticals
• Roche
• Scienion
• Sequenom
• Siemens Healthcare
• Takara Bio
• Targeted Diagnostics & Therapeutics
• Thermo Fisher
• Tosoh
• Veridex
• Wako Pure Chemicals
• Wallac/PE
• Zilla

Contains 585 pages and 85 tables

Contents

1. Introduction

2. Worldwide Market Overview


A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth

3. Major Product Development Opportunities


A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

4. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

5. ALTERNATIVE MARKET PENETRATION STRATEGIES

6. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

7. Worldwide Market and Technology Overview

A. Major Current and Emerging Cancer Diagnostic Tests
  1. BIOCHEMICAL TUMOR MARKERS
  2. ONCOGENES
  3. POLYPEPTIDE GROWTH FACTORS
  4. ECTOPIC HORMONES
  5. COLONY STIMULATING FACTORS
  6. LYMPHOKINES
  7. IMMUNOHISTOCHEMICAL STAINS
  8. EMERGING TUMOR MARKERS
B. Instrumentation Review and Market Needs
C. CURRENT AND EMERGING TECHNOLOGIES
D. Personal Testing

8. France

A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
  Volume Forecasts by Test and Market Segment
  Sales Forecasts by Test and Market Segment
  Major Supplier Sales and Market Shares

9. Competitive Profiles


  Abbott
  AdnaGen
  Agilent Technologies
  Applied Gene Technologies
  Arca Biopharma
  Beckman Coulter/Danaher
  Becton Dickinson
  Biomedical Diagnostics
  bioMerieux
  Bio-Rad
  CellSearch
  Cepheid
  Correlogic Systems/Vermillion
  Decode
  Diadexus
  Diagnocure
  Diasorin
  Eiken Chemical
  Elitech Group
  Epigenomics
  Enterix
  Enzo Biochem
  Exact Sciences
  Fujirebio
  Guided Therapeutics
  Hologic/Gen-Probe
  Kreatech/Leica
  Kyowa Medex
  Mackay Life Sciences
  Myriad Genetics
  OncoLab
  Ortho-Clinical Diagnostics
  Panacea Pharmaceuticals
  Polartechnics
  Polymedco
  PreMD
  Qiagen/Ipsogen
  Quest Diagnostics
  Radient Pharmaceuticals
  Roche
  Scienion
  Sequenom
  Siemens Healthcare
  Takara Bio
  Targeted Diagnostics & Therapeutics
  Thermo Fisher
  Tosoh
  Veridex
  Wako Pure Chemicals
  Wallac/PE
  Zila

10. Appendix: Major Universities and Research Centers Developing Cancer Diagnostic Technologies and Applications

List Of Tables

LIST OF TABLES

Cancer Diagnostic Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
EXECUTIVE SUMMARY Table: France, Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
France, Estimated Cancer Death Rates
France, Laboratories Performing Cancer Diagnostic Tests by Market Segment
France, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
France, Commercial/Private Laboratories Performing Cancer Diagnostic Test by Annual Test Volume
France, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
France, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
France, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
France, Commercial/Private Laboratories Marker Test Volume Forecasts
France, Total Cancer Diagnostic Sales Major Cancer Diagnostic Forecasts by Market Segment
France, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
France, Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
France, Commercial/Private Laboratories Cancer Diagnostic Market Forecasts by Test
France, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
France, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
France, CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market
France, CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Cytokeratins Test Volume and Diagnostics Sales Forecasts by MarketSegment
France, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Interferons Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Interleukins Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
France, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Nucleolar Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Occult Blood Test Volume and Diagnostics Sales Forecasts by MarketSegment
France, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
France, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
France, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
France, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecasts by Market Segment
France, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Sialic Acid Test Volume and Diagnostics Sales Forecasts by MarketSegment
France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
France, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Total Cancer Diagnostics Sales By Major Suppliers
France, AFP Testing Market Diagnostics Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
France, CA 125 Testing Market Diagnostics Sales by Major Supplier
France, CEA Testing Market Diagnostics Sales by Major Supplier
France, NSE Testing Market Diagnostics Sales by Major Supplier
France, PAP Testing Market Diagnostics Sales by Major Supplier
France, PSA Testing Market Diagnostics Sales by Major Supplier